Keywords: Liquisolid; Dissolution enhancement; Leflunomide; SEDDS; BCS class II;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ACL; Aceclofenac; AUC; area under the curve; BBB; blood-brain barrier; BCS; Biopharmaceutical classification system; BVC; bupivacaine; CNS; central nervous system; CUR; Curcumin; DMBA; 7,12-dimethylbenzanthracene; DOX; doxorubicin; DSPE-PEG2000; 1,2-diste
Keywords: Itraconazole; Solubility; Dissolution; Cyclodextrins; BCS Class II; Antifungal
Use of biorelevant dissolution and PBPK modeling to predict oral drug absorption
Keywords: Biorelevant dissolution; Weak base; PBPK modeling; BCS class II; pH dependent solubility; ACAT; advanced compartmental absorption and transit model; ADAM; advanced dissolution, absorption and metabolism model; API; active pharmaceutical ingredient; ASD;
Phospholipid based self-nanoemulsifying self-nanosuspension (p-SNESNS) as a dual solubilization approach for development of formulation with diminished food effect: Fast/fed in vivo pharmacokinetics study in human
Keywords: Lurasidone hydrochloride; Phospholipid; SNESNS; Food effect; BCS class II; pH-dependent solubility;
The Biopharmaceutics Classification System: Subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC
Keywords: BCS Class II; Sub-classification; In vivo predictive dissolution; Simulation; GastroPlusâ¢;
Physicochemical Properties, Form, and Formulation Selection Strategy for a Biopharmaceutical Classification System Class II Preclinical Drug Candidate
Keywords: BCS Class II; polymorphism; solid dispersion; cocrystal; solubility; bioavailability; physicochemical properties;
Pharmaceutical nanotechnologyPreparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications
Keywords: Nanosuspensions; Media milling; BCS Class II; Pharmaceutical films; Hydroxylpropyl methyl cellulose;
Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers
Keywords: BCS Class II; Rofecoxib; Bioavailability; Dissolution; Polyethylene glycol; Gelucire; Polyols; Hydrotrope; Poloxamer; Release kinetics
Development of an in vitro/in vivo correlation for lipid formulations of EMD 50733, a poorly soluble, lipophilic drug substance
Keywords: Poorly soluble drugs; Gélucire 44/14; Vitamin E TPGS; Lipid excipients; BCS class II; Dissolution; Bioavailability; In vitro–in vivo correlations